gsk aim stop aid profiteer one world large manufacturer hivaids drug launch initiative combat smuggle cheaper pill supply poorer african country back europe resale far high price company glaxosmithkline alter packaging change colour pill currently provide develop nation humanitarian agreement estimate drug company lose hundred million dollar year result diversion product way sensitive area big drug company want maintain profit put tremendous pressure provide cheap antiaids drug world poorest nation result drug supply africa now thirty time cheaper sell europe bring medicine within reach million hivpositive african government health care system wide difference price also mean big gain make illegally divert cheaper drug back wealthier country resell high price glaxosmithkline believe coat pill destine africa red dye add new identification code onto pill packaging trade can substantially reduce company say will possible identify specific distributor africa resold humanitarian drug profit supplier europe also involve trade glaxo say distribution newlook drug already begin chemical content identical currently sell europe 